In this study, we examined DLG5 expression in paired of TAM‐sensitive and resistant breast cancer tissues and employed TAM‐sensitive and resistant ER+ breast cancer cells to determine the effect of altered DLG5 expression on TAM sensitivity, apoptosis and stemness as well as TAZ expression. Here, DLG5 is linked to breast carcinoma.